Skip to main content

Table 5 Immune related adverse effects

From: Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies

 

N = 157

Immune side effects

 No

98 (62.4%)

 Yes

59 (37.6%)

Pneumonitis

 Grade 1–2

13 (8.2%)

 Grade ≥ 3

2 (1.3%)

Colitis

 Grade 1–2

7 (4.4%)

 Grade ≥ 3

1 (0.6%)

Rash

 Grade 1–2

10 (6.3%)

 Grade ≥ 3

1 (0.6%)

Thyroiditis

 Grade 1–2

27 (17.2%)

 Grade ≥ 3

2 (1.3%)

Hepatitis

 Grade 1–2

7 (4.4%)

 Grade ≥ 3

1 (0.6%)

Nephritis

 Grade 1–2

7 (4.4%)

Steroid use due to side effects

N = 59

 No

27 (45.8%)

 Yes

32 (54.2%)